Backed by extensive experience in the healthcare sector, the fund manager has successfully executed over 20 deals across North America and Europe. With a strategic focus on early-stage investments, this operator-first approach has led to notable exits in telemedicine and biotech. Their deep understanding of market trends has driven a data-driven investment style, positioning the portfolio for sustainable growth in a rapidly evolving landscape.